CCO.AX stock slipped 14.29% to A$0.003 in pre-market trading on 07 Mar 2026, making The Calmer Co International Limited a top loser on the ASX. The move follows minimal volume of 600 shares and a thin float that amplifies price swings. Investors should note the company trades in the Consumer Defensive — Packaged Foods sector and shows negative earnings per share of -0.01. We review price drivers, liquidity, valuation, and a model forecast that suggests material downside unless operational metrics improve.

CCO.AX stock price action and liquidity

The Calmer Co International Limited (CCO.AX) opened at A$0.003 and is trading at the day range A$0.003–A$0.003 pre-market. One-day change is -14.29%, and year-to-date performance sits below the 50-day average of A$0.00389. Volume is extremely light at 600 shares versus an average volume of 3,793,594, highlighting low liquidity and wide bid-ask risk.

Valuation snapshot and financial ratios

CCO.AX carries a market capitalisation near A$9.18M and a negative PE ratio of -2.68, reflecting recent losses. Price-to-book stands at 48.23, while price-to-sales is 1.13. Current ratio is 1.85, and debt-to-equity is 22.94, signalling meaningful gearing relative to a tiny market cap. These metrics suggest stretched valuation and execution risk for a small packaged foods player.

Operational performance and cash flow

The Calmer Co reports revenue per share of A$0.00269 with net income per share of -A$0.00112. Operating cash flow per share is negative at -A$0.00097, and free cash flow per share is -A$0.00098. Inventory days are elevated at 82.52, while receivables turnover is healthy at 12.75, which points to sales but tight cash conversion at current scales.

Technical picture and sector context

Technically the stock is showing oversold oscillators (CCI -101.99) and a Relative Strength Index near 39.76, but average true range and Bollinger data are not meaningful at this penny level. In the ASX Consumer Defensive sector, larger packaged foods peers trade on much higher liquidity and average P/E near 28.70, underscoring the gap between CCO.AX and sector comparables.

Meyka AI rating and model forecast

Meyka AI rates CCO.AX with a score of 61.44 out of 100 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 comparisons, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month baseline of A$0.00177 versus the current A$0.003, implying a -40.86% downside. Forecasts are model-based projections and not guarantees. Investors should weigh this model output alongside company announcements and liquidity constraints.

Risks, catalysts and trading strategy

Key risks include continued negative EPS, limited cash flow, and concentrated share supply that can magnify moves. Catalysts that could stabilise the stock include stronger US or Fiji channel sales, positive earnings surprise, or a reduction in net debt. For traders, the stock’s low liquidity suits speculative, size-limited positions and requires limit orders and strict stop rules.

Final Thoughts

CCO.AX stock is one of the ASX pre-market top losers on 07 Mar 2026, down 14.29% to A$0.003 on very low volume. Fundamentals show negative EPS (-A$0.01), weak cash flow, and a high price-to-book ratio (48.23), signalling valuation stress for a micro-cap packaged foods business. Meyka AI’s forecast model projects A$0.00177 over 12 months, implying around -40.86% from today’s price; alternative scenarios place a conservative bear case near A$0.0015 and a bull case near its 52-week high of A$0.006. Our analysis highlights liquidity as the immediate market risk and weak profitability as the structural risk. Use tight position sizing and monitor company announcements on the ASX and sales updates at the company website. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.